glp-1 drugs pharmaceutical companies 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth glp-1 drugs pharmaceutical companies partnerships

The enhancement of the action of GLP-1 receptors using GLP-1 receptor agonists has a beneficial effect on the treatment of diabetes based on the lowering of serum glucose (Figure 9)

2,3 In addition to these mechanisms, GLP-1 RAs also delay gastric emptying, thereby contributing to enhanced postprandial glucose regulation and increased satiety, ultimately supporting reduced caloric intake and weight management

doi: 10.1056/NEJMoa1506930 [DOI] [PMC free article] [PubMed] [Google Scholar] 259

Diabetologia 65 , 12511261 (2022)

This twice daily injectable established the entire drug class

3B indicated that, although the P -value exceeded 0.1 and the I 2 statistic was greater than 50%, the presence of heterogeneity could not be disregarded [22, 23]